Sign In
to Vote &
Create Storyboards.
 
Pharmacyclics Slips, Looks Buyable Below $120 Aggressive biotech investors and traders should consider PCYC on dips below $120 like we are seeing on Thursday.
0
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard